» Articles » PMID: 24880488

Genome Editing in the Human Malaria Parasite Plasmodium Falciparum Using the CRISPR-Cas9 System

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2014 Jun 2
PMID 24880488
Citations 358
Authors
Affiliations
Soon will be listed here.
Abstract

Genome manipulation in the malaria parasite Plasmodium falciparum remains largely intractable and improved genomic tools are needed to further understand pathogenesis and drug resistance. We demonstrated the CRISPR-Cas9 system for use in P. falciparum by disrupting chromosomal loci and generating marker-free, single-nucleotide substitutions with high efficiency. Additionally, an artemisinin-resistant strain was generated by introducing a previously implicated polymorphism, thus illustrating the value of efficient genome editing in malaria research.

Citing Articles

Maintenance of pyrophosphate homeostasis in multiple subcellular compartments is essential in .

Nwankwo I, Ke H bioRxiv. 2025; .

PMID: 40027813 PMC: 11870574. DOI: 10.1101/2025.02.20.639246.


Constitutive expression of Cas9 and rapamycin-inducible Cre recombinase facilitates conditional genome editing in Plasmodium berghei.

Das S, Unhale T, Marinach C, Valeriano Alegria B, Roux C, Madry H Sci Rep. 2025; 15(1):2949.

PMID: 39849074 PMC: 11758014. DOI: 10.1038/s41598-025-87114-4.


A scalable CRISPR-Cas9 gene editing system facilitates CRISPR screens in the malaria parasite Plasmodium berghei.

Jonsdottir T, Paoletta M, Ishizaki T, Hernandez S, Ivanova M, Herrera Curbelo A Nucleic Acids Res. 2025; 53(2.

PMID: 39844455 PMC: 11754126. DOI: 10.1093/nar/gkaf005.


transcription factor AP2-06B is mutated at high frequency in Southeast Asia but does not associate with drug resistance.

Shi Q, Wang C, Yang W, Ma X, Tang J, Zhang J Front Cell Infect Microbiol. 2025; 14():1521152.

PMID: 39835275 PMC: 11744005. DOI: 10.3389/fcimb.2024.1521152.


Identification of an artemisinin-resistant kelch13 R515K mutant parasite in Senegal.

Sene S, Pouye M, Martins R, Diallo F, Mangou K, Bei A Front Parasitol. 2025; 2():1076759.

PMID: 39816817 PMC: 11731788. DOI: 10.3389/fpara.2023.1076759.


References
1.
Ganesan S, Morrisey J, Ke H, Painter H, Laroiya K, Phillips M . Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection. Mol Biochem Parasitol. 2011; 177(1):29-34. PMC: 3057331. DOI: 10.1016/j.molbiopara.2011.01.004. View

2.
Pfander C, Anar B, Schwach F, Otto T, Brochet M, Volkmann K . A scalable pipeline for highly effective genetic modification of a malaria parasite. Nat Methods. 2011; 8(12):1078-82. PMC: 3431185. DOI: 10.1038/nmeth.1742. View

3.
Deshmukh A, Srivastava S, Herrmann S, Gupta A, Mitra P, Gilberger T . The role of N-terminus of Plasmodium falciparum ORC1 in telomeric localization and var gene silencing. Nucleic Acids Res. 2012; 40(12):5313-31. PMC: 3384324. DOI: 10.1093/nar/gks202. View

4.
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N . A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2013; 505(7481):50-5. PMC: 5007947. DOI: 10.1038/nature12876. View

5.
Salanti A, Staalsoe T, Lavstsen T, Jensen A, Sowa M, Arnot D . Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol. 2003; 49(1):179-91. DOI: 10.1046/j.1365-2958.2003.03570.x. View